Suppliers / Shandong Haiyou Freda Pharmaceutical

Shandong Haiyou Freda Pharmaceutical

China Updated 9 July 2026

Shandong Haiyou Freda Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file and 2 valid CEPs across a filed portfolio of 3 molecules.

1
active US DMFs
2
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Linyi, China Not on file

What they file, and where

Molecule Regulators Docs
Gliclazide EDQM 1
Tadalafil EDQM 1
Upadacitinib US FDA 1

Also appears on these molecule pages

Questions about Shandong Haiyou Freda Pharmaceutical

Does Shandong Haiyou Freda Pharmaceutical hold a US DMF or a CEP?
Shandong Haiyou Freda Pharmaceutical holds 1 active US drug master file and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Shandong Haiyou Freda Pharmaceutical manufacture?
1 registered site is on record, in China (Linyi). Every site is listed on this page with the register it came from.
What does Shandong Haiyou Freda Pharmaceutical make?
3 molecules are on record against Shandong Haiyou Freda Pharmaceutical, including Gliclazide, Tadalafil and Upadacitinib. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shandong Haiyou Freda Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability